Bicara Therapeutics Inc. (BCAX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-11) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-30) · 99.1 | 8-K (2026-02-26) | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 · 99.2 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Deficit | — |
|
| Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Deficit/equity | — |
|
| Condensed Consolidated Statements of Stockholders Equity | — |
|
| Consolidated Statement of Cash Flows | ||
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Equity (deficit) | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Accrued Expenses and Other Current Liabilitiesrelated Party | — |
|
| Commitments and Contingencies | ||
| Common Stock | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Defined Contribution Plan | ||
| Description of Business, Organization, and Liquidity | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Investments | — |
|
| Leases | ||
| Marketable Securities | ||
| Pay Vs Performance Disclosure | ||
| Redeemable Convertible Preferred Stock | ||
| Segment Reporting | ||
| Significant Agreements | ||
| Significant Agreements Related Parties | ||
| Stock-based Compensation | ||
| Stockholders Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||